Reneo Pharmaceuticals (RPHM) Short Interest Ratio & Short Volume → CBOE shift unlocks new weekend income strategy (From DTI) (Ad) Free RPHM Stock Alerts $1.65 0.00 (0.00%) (As of 03/27/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Reneo Pharmaceuticals Short Interest DataCurrent Short Volume2,820,000 sharesPrevious Short Volume2,590,000 sharesChange Vs. Previous Month+8.88%Dollar Volume Sold Short$4.68 millionShort Interest Ratio / Days to Cover5.6Last Record DateMarch 15, 2024Outstanding Shares33,310,000 sharesFloat Size22,170,000 sharesShort Percent of Float12.72%Today's Trading Volume47,064 sharesAverage Trading Volume172,641 sharesToday's Volume Vs. Average27% Short Selling Reneo Pharmaceuticals ? Sign up to receive the latest short interest report for Reneo Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRPHM Short Interest Over TimeRPHM Days to Cover Over TimeRPHM Percentage of Float Shorted Over Time Ad DTIWarning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…Watch the presentation here Reneo Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/20242,820,000 shares $4.68 million +8.9%12.7%5.6 $1.66 2/29/20242,590,000 shares $4.27 million +29.5%11.7%2.5 $1.65 2/15/20242,000,000 shares $3.34 million +22.7%9.0%1.9 $1.67 1/31/20241,630,000 shares $2.67 million +10.1%7.4%1.5 $1.64 1/15/20241,480,000 shares $2.49 million -15.4%6.7%1.4 $1.68 12/31/20231,750,000 shares $2.80 million -50.3%7.8%1.8 $1.60 Get the Latest News and Ratings for RPHM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Reneo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/15/20233,520,000 shares $5.00 million +30.9%15.6%4 $1.42 11/30/20232,690,000 shares $17.05 million +8.0%13.9%13.1 $6.34 11/15/20232,490,000 shares $16.46 million +5.5%12.8%15 $6.61 10/31/20232,360,000 shares $19.09 million +3.1%12.0%15.6 $8.09 10/15/20232,290,000 shares $16.97 million +12.3%11.6%14.9 $7.41 9/30/20232,040,000 shares $15.53 million -1.9%10.4%13.7 $7.62 9/15/20232,080,000 shares $15.25 million +2.5%10.6%14.7 $7.33 8/31/20232,030,000 shares $12.22 million +16.7%10.3%12.2 $6.02 8/15/20231,740,000 shares $9.81 million +18.4%8.9%11 $5.64 7/31/20231,470,000 shares $11.80 million +20.5%7.5%9.3 $8.03 7/15/20231,220,000 shares $8.98 million +36.9%6.2%7.4 $7.36 6/30/2023891,200 shares $5.85 million +83.1%6.0%5.5 $6.56 6/15/2023486,700 shares $3.49 million -12.3%3.3%3.4 $7.18 5/31/2023555,200 shares $4.44 million +117.2%5.1%5.4 $8.00 5/15/2023255,600 shares $2.10 million +121.1%2.3%2.4 $8.20 4/30/2023115,600 shares $1.18 million -9.2%1.2%1.3 $10.22 4/15/2023127,300 shares $865,640.00 -7.8%1.1%1.8 $6.80 3/31/2023138,100 shares $825,838.00 +19.5%1.2%2.4 $5.98 3/15/2023115,600 shares $502,860.00 +21.3%1.1%2.1 $4.35 2/28/202395,300 shares $289,712.00 +0.5%0.9%2 $3.04 2/15/202394,800 shares $265,440.00 +19.6%0.9%3 $2.80 1/31/202379,300 shares $214,903.00 -2.3%0.7%2.7 $2.71 1/15/202381,200 shares $211,120.00 +59.2%0.7%3.1 $2.60 12/30/202251,000 shares $118,830.00 +6.9%0.5%2.3 $2.33 12/15/202247,700 shares $104,940.00 -24.3%0.4%2.6 $2.20 11/30/202263,000 shares $140,490.00 -7.2%0.6%3 $2.23 11/15/202267,900 shares $177,219.00 -3.1%0.6%3 $2.61 10/31/202270,100 shares $246,752.00 -7.6%0.7%2.6 $3.52 10/15/202275,900 shares $227,700.00 +14.0%0.7%1.6 $3.00 9/30/202266,600 shares $223,110.00 -14.5%0.6%1.4 $3.35 9/15/202277,900 shares $377,815.00 +8.7%0.7%1.1 $4.85 8/31/202271,700 shares $225,855.00 -2.2%0.7%0.9 $3.15 8/15/202273,300 shares $209,638.00 -35.0%0.7%0.8 $2.86 7/31/2022112,800 shares $398,184.00 -18.4%1.0%1.1 $3.53Your $200 account credit is about to expire (Ad)Update to MarketBeat All Access and Save $300 on Your Annual SubscriptionStart Your Risk-Free Trial Here RPHM Short Interest - Frequently Asked Questions What is Reneo Pharmaceuticals' current short interest? Short interest is the volume of Reneo Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 15th, traders have sold 2,820,000 shares of RPHM short. 12.72% of Reneo Pharmaceuticals' shares are currently sold short. Learn More on Reneo Pharmaceuticals' current short interest. What is a good short interest ratio for Reneo Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RPHM shares currently have a short interest ratio of 6.0. Learn More on Reneo Pharmaceuticals's short interest ratio. Which institutional investors are shorting Reneo Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Reneo Pharmaceuticals: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Reneo Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.72% of Reneo Pharmaceuticals' floating shares are currently sold short. Is Reneo Pharmaceuticals' short interest increasing or decreasing? Reneo Pharmaceuticals saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 2,820,000 shares, an increase of 8.9% from the previous total of 2,590,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Reneo Pharmaceuticals' float size? Reneo Pharmaceuticals currently has issued a total of 33,310,000 shares. Some of Reneo Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Reneo Pharmaceuticals currently has a public float of 22,170,000 shares. How does Reneo Pharmaceuticals' short interest compare to its competitors? 12.72% of Reneo Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Reneo Pharmaceuticals: NextCure, Inc. (3.98%), Clene Inc. (0.20%), Rallybio Co. (7.43%), Homology Medicines, Inc. (0.81%), Aadi Bioscience, Inc. (6.50%), SCYNEXIS, Inc. (2.54%), Immix Biopharma, Inc. (3.08%), Eledon Pharmaceuticals, Inc. (0.15%), YS Biopharma Co., Ltd. (0.65%), Unicycive Therapeutics, Inc. (0.23%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short Reneo Pharmaceuticals stock? Short selling RPHM is an investing strategy that aims to generate trading profit from Reneo Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Reneo Pharmaceuticals? A short squeeze for Reneo Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RPHM, which in turn drives the price of the stock up even further. How often is Reneo Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RPHM, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies: NextCure Short Interest Data Clene Short Interest Data Rallybio Short Interest Data Homology Medicines Short Interest Data Aadi Bioscience Short Interest Data SCYNEXIS Short Interest Data Immix Biopharma Short Interest Data Eledon Pharmaceuticals Short Interest Data YS Biopharma Short Interest Data Unicycive Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RPHM) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap Profits